What is Enterobacter (a type of bacteria)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Enterobacter is a genus of gram-negative, rod-shaped bacteria belonging to the family Enterobacteriaceae, commonly found in the human gastrointestinal tract, soil, water, and sewage, and can cause various infections, particularly in healthcare settings and immunocompromised individuals, with the most clinically significant species including Enterobacter cloacae and Enterobacter aerogenes (now reclassified as Klebsiella aerogenes) 1.

Key Characteristics of Enterobacter

  • Gram-negative, rod-shaped bacteria
  • Belong to the family Enterobacteriaceae
  • Commonly found in the human gastrointestinal tract, soil, water, and sewage
  • Can exist as normal gut flora, but also opportunistic pathogens
  • Can cause urinary tract infections, pneumonia, bloodstream infections, and surgical site infections

Concerns and Challenges

  • Often carry resistance to multiple antibiotics, including third-generation cephalosporins due to inducible AmpC beta-lactamases
  • Treatment typically requires carbapenems (like meropenem or imipenem), fluoroquinolones, or aminoglycosides, depending on susceptibility testing
  • Infection control measures in healthcare settings are crucial to prevent Enterobacter outbreaks, including proper hand hygiene, contact precautions, and environmental cleaning
  • Ability to rapidly develop resistance during treatment makes them a significant challenge in clinical practice 2

Recent Guidance and Recommendations

  • The Infectious Diseases Society of America provides guidance on the treatment of extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa) 1
  • New antimicrobials like ceftazidime-avibactam, meropenem-vaborbactam, imipenem-relebactam, cefiderocol, and plazomicin have the potential to overcome resistance mechanisms in Enterobacterales, including different classes of carbapenemases 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.